Battling Lower Respiratory Tract Infections: Scope of Levofloxacin Dr. Kamal Kant Kohli27 Jan 2022 10:27 AM ISTFluoroquinolones are highly effective antibiotics with many advantageous pharmacokinetic properties including high oral bioavailability, a large...
Molnupiravir (MK-4482/EIDD-2801) inhibits SARS-CoV-2 replication in Syrian Hamster Model Dr. Kamal Kant Kohli25 Jan 2022 11:04 AM ISTAn effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in...
Revisiting the need for Early management of Influenza: Role of Oseltamivir Dr. Kamal Kant Kohli20 Jan 2022 11:33 AM ISTInfluenza, commonly known as flu, is a contagious viral infection caused mainly due to influenza viruses A and B (1). It usually attacks the...
Understanding Monoclonal Antibody in Treatment of Hospitalized Patients with COVID-19 Dr. Kamal Kant Kohli18 Jan 2022 12:45 PM ISTHospitalized COVID-19 patients reported having high mortality rates (10-30%). Casirivimab and imdevimab antibody cocktail (REGEN-COV®) are authorized...
Molnupiravir Blocks SARS-CoV-2 Transmission in Ferrets Dr. Kamal Kant Kohli14 Jan 2022 11:19 AM ISTThe coronavirus disease (COVID)-19 pandemic is exerting a global impact on human health. Interrupting widespread community transmission is paramount...
Disease Review: Understanding Incidence of Idiopathic pulmonary fibrosis (IPF) in India, Diagnosis and Treatment Dr. Anil Mehndiratta10 Jan 2022 12:24 PM ISTIdiopathic pulmonary fibrosis (IPF), previously known as "Hamman Rich syndrome", "cryptogenic fibrosing alveolitis", and "cirrhosis of the lung", is a...
Breakthrough COVID-19 Infections: Decoding scope of Monoclonal Antibody Dr. Kamal Kant Kohli7 Jan 2022 10:46 AM ISTDespite the effectiveness of COVID-19 vaccines, breakthrough infections have been reported. Breakthrough COVID-19 may occur in fully vaccinated...
Clinical Review of Salbutamol in Reversible Obstructive Airway Diseases Dr. Kamal Kant Kohli25 Dec 2021 12:04 PM ISTChronic Obstructive Airway Disease in India: Overview & ChallengesChronic Obstructive Airway Diseases: The Rising Burden in India: India has a...
Decoding Molnupiravir for Non hospitalized COVID-19 Patients Dr. Kamal Kant Kohli24 Dec 2021 12:15 PM ISTIn the Covid-19 pandemic, a substantial portion of patients need hospitalization, predominantly older adults and persons with preexisting conditions...
Relieving Obstructive Airway Diseases-Clinical Review and Use of Levosalbutamol-Beclomethasone Combination Dr. Kamal Kant Kohli18 Dec 2021 12:15 PM ISTObstructive Airway IllnessesI- Indian Clinician's Dilemma and Challenges - Asthma is a chronic inflammatory airway disease leading to airway...
Managing allergic rhinitis and asthma: Analyzing the role of Montelukast-Levocetirizine combination Dr. Kamal Kant Kohli15 Dec 2021 11:57 AM ISTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
What was the optimal dose of pirfenidone in large studies on idiopathic pulmonary fibrosis? Dr. Kamal Kant Kohli9 Dec 2021 12:00 PM ISTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease that is characterized by the irreversible loss of lung function....
